• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

Icotinib (Hydrochloride)

(CAS: 1204313-51-8)

Suppliers of Icotinib (Hydrochloride)

Company Name Email Tel Country
Active Biochem [email protected]; [email protected] 1-800-857-0985 (USA Toll Free#) USA

Fax: 1-201-884-1288 (USA Fax#)Purity: Brand:

Price and Availability: USD400/50mg ()

AdooQ BioScience, LLC [email protected] 855-GO-ADOOQ (855-462-3667) (US & Canada Toll Free) 866-930-6790 (US & Canada Toll Free) +1-323-389-9269 (Outside of US & Canada) USA

Fax: 866-333-9607 (US & Canada Toll Free) +1-323-606-8156 (Outside of US & Canada)Purity: Brand:

Price and Availability: USD200/5mg ()

Apexbio Technology LLC [email protected] +1-832-696-8203 USA

Fax: +1-832-641-3177Purity: Brand:

Price and Availability: USD238/5mg (In stock)

CHEMSCENE, LLC [email protected] 732-484-9848 USA

Fax: 888-484-5008Purity: >98% Brand:

DC Chemicals [email protected]; [email protected] +86-21-58447131 China

Fax: +86-21-61642470Purity: Brand:

Price and Availability: USD550/100mg (In stock)

MedChemexpress Co., Ltd. [email protected] 609-228-6898 USA

Fax: 609-228-5909Purity: >98% Brand:

Price and Availability: USD236/5mg (In stock) USD340/10mg (In stock) USD996/50mg (In stock)
Quality Control & MSDS Files: NP-HPLC HNMR MSDS

MedKoo Biosciences, Inc. [email protected] 919-279-0682 USA

Fax: 919-980-4831Purity: Brand:

Price and Availability: USD150/10mg ()

Shanghai Haoyuan Chemexpress Co., Ltd. [email protected] +86 (21) 5187-0955 / +86 (21) 5895-5995 China

Fax: +86 (21) 5895-5996Purity: >98% Brand:

Price and Availability: USD236/5mg (In stock) USD340/10mg (In stock) USD996/50mg (In stock)

Target Molecule Corp. [email protected] (857) 239-0968 USA

Fax: 857-239-8801Purity: .98 Brand: TargetMol

Price and Availability: USD89/1mg () USD197/5mg () USD272/10mg () USD392/50mg ()

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of Icotinib (Hydrochloride)

Icotinib Hcl(BPI-2009H) is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC(50) of 5 nM, including it's mutants of EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R). IC50 value: 5 nM Target: EGFR and EGFR mutants in vitro: Icotinib inhibits EGFR activity in a dose-dependent manner, with an IC50 value of 5 nM and complete inhibition at 62.5 nM.

Solubility of Icotinib (Hydrochloride)

Solubility Sources
DMSO MedChemexpress Co., Ltd.

Storage Condition of Icotinib (Hydrochloride)

Storage Condition Sources

MSDS Information

MSDS Sources
MedChemexpress Co., Ltd.

Quality Control and Spectral Data

QC Reports Sources
[NP-HPLC] [HNMR] MedChemexpress Co., Ltd.

Mechanism and Indications

Signaling Pathways JAK/STAT Signaling Protein Tyrosine Kinase/RTK
Target EGFR
Research Area Cancer
Indications Metastasis Metastatic non small cell lung cancer

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Icotinib (Hydrochloride) Zhejiang Beta Pharma Inc Metastasis 2013/6/30 2014/12/31 Phase 4 Clinical
Icotinib (Hydrochloride) Zhejiang Beta Pharma Inc Metastatic non small cell lung cancer 2012/10/31 2014/4/30 Phase 4 Clinical
Icotinib (Hydrochloride) Zhejiang Beta Pharma Inc Metastatic non small cell lung cancer 2012/8/31 2013/12/31 Phase 4 Clinical
Icotinib (Hydrochloride) Zhejiang Beta Pharma Inc Metastatic non small cell lung cancer 2012/7/31 2014/10/31 Phase 4 Clinical
Icotinib (Hydrochloride) Zhejiang Beta Pharma Inc Metastatic non small cell lung cancer 2011/9/30 2013/11/30 Phase 4 Clinical
Icotinib (Hydrochloride) - Launched

Chemical Information

M.Wt Formula CAS No. Synonyms
427.88 C22H22ClN3O4 1204313-51-8 BPI-2009H; N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride

Structure Information of Icotinib (Hydrochloride)

Smiles C#CC1=CC(NC2=C(C=C(OCCOCCOCCO3)C3=C4)C4=NC=N2)=CC=C1.[H]Cl
InChI InChI=1S/C22H21N3O4.ClH/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20;/h1,3-5,12-15H,6-11H2,(H,23,24,25);1H

Related Products

Other Form Products of Icotinib (Hydrochloride)

Name CAS Formula Suppliers
Icotinib 610798-31-7 C22H21N3O4 8

Recommended Products in Same Target

Name CAS Formula Suppliers
Ginsenoside Rh2 78214-33-2 C36H62O8 6
Mutated EGFR-IN-1 1421372-66-8 C25H31N7O 6
AZD-9291 (mesylate) 1421373-66-1 C29H37N7O5S 4
Mutant EGFR inhibitor 1421373-62-7 C27H30ClN7O2 5
AZD-9291 1421373-65-0 C28H33N7O2 16
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 4
WHI-P180 211555-08-7 C16H15N3O3 5
Gefitinib (hydrochloride) 184475-55-6 C22H25Cl2FN4O3 6
Erlotinib (mesylate) 248594-19-6 C23H27N3O7S 4
BGB-102 807640-87-5 C22H25BrN4O2 4
Poziotinib 1092364-38-9 C23H21Cl2FN4O3 10
CO-1686 (hydrobromide) 1446700-26-0 C27H29BrF3N7O3 10
CO-1686 1374640-70-6 C27H28F3N7O3 9
CNX-2006 1375465-09-0 C26H27F4N7O2 8
PD 168393 194423-15-9 C17H13BrN4O 12
AG 18 118409-57-7 C10H6N2O2 14
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 9
Chrysophanic acid 481-74-3 C15H10O4 18
AG-1478 153436-53-4 C16H14ClN3O2 10
Mubritinib 366017-09-6 C25H23F3N4O2 22

Recommended Products in the Same Indication

Name CAS Formula Suppliers
LDK378 1032900-25-6 C28H36ClN5O3S 10
Pemetrexed (disodium) 150399-23-8 C20H19N5Na2O6 20
Volasertib 755038-65-4 C34H50N8O3 8
ALK inhibitor 1 761436-81-1 C23H28BrN7O3S 4
Olaparib 763113-22-0 C24H23FN4O3 10
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 9
MGCD-265 875337-44-3 C26H20FN5O2S2 5
AT9283 896466-04-9 C19H23N7O2 6
AT-101 90141-22-3 C30H30O8 13
Tivantinib 905854-02-6 C23H19N3O2 8
INCB024360 914471-09-3 C9H7ClFN5O2 9
BEZ235 915019-65-7 C30H23N5O 11
MK-0752 471905-41-6 C21H21ClF2O4S 7
Sunitinib 557795-19-4 C22H27FN4O2 16
AZD8330 869357-68-6 C16H17FIN3O4 6
Motesanib (Diphosphate) 857876-30-3 C22H29N5O9P2 9
LY2228820 862507-23-1 C26H37FN6O6S2 7
LY2603618 911222-45-2 C18H22BrN5O3 6
Crizotinib 877399-52-5 C21H22Cl2FN5O 19
Ganetespib 888216-25-9 C20H20N4O3 11

Chemical and Physical Properties

Appearance:White to off-white solid Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:

Reference

[1].Tan F, et al. Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies. Lung Cancer. 2012 May;76(2):177-82.
Icotinib, one of the leading compounds selected from our compound library, was found to be a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC(50) of 5 nM. When profiled with 88 kinases, Icotinib only showed meaningful inhibitory activity to EGFR and its mutants. Icotinib blocked EGFR-mediated intracellular tyrosine phosphorylation (IC(50)=45 nM) in the human epidermoid carcinoma A431 cell line and inhibits tumor cell proliferation. In vivo studies demonstrated that Icotinib exhibited potent dose-dependent antitumor effects in nude mice carrying a variety of human tumor-derived xenografts. The drug was well tolerated at doses up to 120 mg/kg/day in mice without mortality or significant body weight loss during the treatment. A head to head randomized, double blind phase III trial using Gefitinib as an active control for patients with advanced non-small cell lung cancer (NSCLC) was finished recently (Trial registration ID: NCT01040780). The data shows that Icotinib was non-inferior to Gefitinib in terms of median progression free survival (PFS) and safety superior favor to Icotinib compared to Gefitinib.

Tags: buy Icotinib (Hydrochloride) | Icotinib (Hydrochloride) IC50 | Icotinib (Hydrochloride) price | Icotinib (Hydrochloride) cost | Icotinib (Hydrochloride) solubility | Icotinib (Hydrochloride) purchase | Icotinib (Hydrochloride) manufacturer | Icotinib (Hydrochloride) research buy | Icotinib (Hydrochloride) order | Icotinib (Hydrochloride) MSDS | Icotinib (Hydrochloride) chemical structure | Icotinib (Hydrochloride) Storage condition | Icotinib (Hydrochloride) molecular weight | Icotinib (Hydrochloride) mw | Icotinib (Hydrochloride) datasheet | Icotinib (Hydrochloride) supplier | Icotinib (Hydrochloride) cell line | Icotinib (Hydrochloride) NMR | Icotinib (Hydrochloride) MS | Icotinib (Hydrochloride) IR | Icotinib (Hydrochloride) solubility | Icotinib (Hydrochloride) Safe information | Icotinib (Hydrochloride) Qc and Spectral Information | Icotinib (Hydrochloride) Clinical Information | Icotinib (Hydrochloride) Clinical Trial | Icotinib (Hydrochloride) Route of Synthesis | Icotinib (Hydrochloride) storage condition | Icotinib (Hydrochloride) diseases and conditions | Icotinib (Hydrochloride) flash point | Icotinib (Hydrochloride) boiling point | Icotinib (Hydrochloride) melting point | Icotinib (Hydrochloride) storage condition | Icotinib (Hydrochloride) brand